ORIX director reports 2000 deferred share units

ORIX CORP director Kato Mami filed an initial ownership statement reporting deferred share-based compensation.

Rhea-AI Filing Summary

ORIX CORP director Kato Mami filed an initial ownership statement reporting deferred share-based compensation. The filing shows an indirect holding of 2000 share-based compensation points through a Board Incentive Plan Trust. Each point represents a right to receive one share of ORIX common stock upon retirement.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Kato Mami

Role Director

Type	Security	Shares	Price	Value
holding	Share-based Compensation Points	--	--	--

Holdings After Transaction: Share-based Compensation Points — 2,000 contracts (Indirect, By Board Incentive Plan Trust)

Footnotes (2)

1. F1. The reported derivative securities represent share-based compensation granted under ORIX Corporation's share-based compensation program, which entitles the Reporting Person to receive the stated amount of Common Stock upon retirement.
2. F2. Each point represents a right to receive one share of Common Stock.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does ORIX (IX) director Kato Mami report in this Form 3?

Kato Mami reports an initial indirect holding of 2000 share-based compensation points. These points are part of ORIX’s share-based compensation program and are held through a Board Incentive Plan Trust, rather than as directly owned common shares.

How do the share-based compensation points for ORIX (IX) work?

Each point represents a right to receive one share of ORIX common stock. Under the company’s share-based compensation program, the reported 2000 points entitle Kato Mami to receive 2000 shares of common stock upon retirement, subject to the program’s terms.

Are the ORIX (IX) share-based compensation holdings direct or indirect?

The 2000 share-based compensation points are reported as an indirect holding. They are held by a Board Incentive Plan Trust under ORIX’s share-based compensation program, rather than being directly owned common shares in Kato Mami’s personal name.

Does this ORIX (IX) Form 3 show any stock purchases or sales?

The Form 3 does not show any stock purchases or sales. It reports a holding entry of 2000 share-based compensation points as derivative securities, reflecting compensation awarded under ORIX’s share-based compensation program rather than market transactions.

When can the ORIX (IX) share-based compensation points be converted to stock?

The footnotes state the reported derivative securities entitle Kato Mami to receive the stated amount of common stock upon retirement. This means the 2000 share-based compensation points convert into shares when retirement conditions in the compensation program are met.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/18/2026 - 08:45 AM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Kato Mami

(Last) (First) (Middle)

WORLD TRADE CENTER BUILDING, SOUTH TOWER

2-4-1 HAMAMATSU-CHO, MINATO-KU

(Street)

TOKYO JAPAN 105-5135

(City) (State) (Zip)

JAPAN

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
ORIX CORP [ IX ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Share-based Compensation Points	(1)	(1)	Common Stock	2,000	(2)	I	By Board Incentive Plan Trust

Explanation of Responses:

1. The reported derivative securities represent share-based compensation granted under ORIX Corporation's share-based compensation program, which entitles the Reporting Person to receive the stated amount of Common Stock upon retirement.

2. Each point represents a right to receive one share of Common Stock.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney The professional name of the Reporting Person is Mami Yunoki.

	/s/ Tomohiko Ishihara, as Attorney-in-Fact for Mami Kato	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)